ZEB1 and pancreatic neoplasm: In pancreatic cancer, FoxM1 is overexpressed and promotes EMT by the up-regulation of mesenchymal cell markers such as ZEB1, ZEB2, SLUG, and vimentin [117] (Fig. 4a).